Weighted Gene Coexpression Network Analysis Identifies Crucial Genes Involved in Coronary Atherosclerotic Heart

Jinli Bao1

  • 1Department of Internal Medicine, Municipal Hospital, Zaozhuang, Shandong 277100, China.

Disease Markers
|August 12, 2022
PubMed
Abstract

Insights

This study identifies key genes and pathways involved in coronary atherosclerotic heart disease (CHD) pathogenesis. Findings offer novel biomarkers and therapeutic targets for improving CHD patient outcomes.

Area of Science:

  • Genomics
  • Cardiovascular Research
  • Bioinformatics

Background:

  • Coronary atherosclerotic heart disease (CHD) poses a significant mortality risk with an unclear pathogenic mechanism.
  • There is an urgent need for novel biomarkers and therapeutic strategies for CHD.
  • Understanding CHD pathogenicity is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify crucial gene modules and hub genes associated with coronary atherosclerosis using weighted gene coexpression network analysis (WGCNA).
  • To explore the biological pathways implicated in CHD development.
  • To uncover potential novel biomarkers for CHD.

Main Methods:

  • Weighted gene coexpression network analysis (WGCNA) was performed on the GSE90074 coronary atherosclerosis dataset.
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted.
  • Protein-protein interaction (PPI) network analysis was utilized to identify hub genes.

Main Results:

  • The yellow module was identified as the most critical module associated with CHD.
  • Enriched pathways included inflammatory response, ERK1/2 cascade, lipid catabolism, oxidative stress, apoptosis, and NF-kappa B signaling.
  • Top five hub genes (MMP14, CD28, CaMK4, RGS1, DDAH1) were identified as crucial for CHD development.

Conclusions:

  • The study presents prognostic insights, novel hub genes, and signaling pathways for coronary atherosclerosis treatment.
  • Further investigation into the biological roles of identified genes and pathways is warranted.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
48
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
29
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21